Biblio
2013
Russell Y Cruz, C., Micklethwaite, K.P., Savoldo, B., Ramos, C.A., Lam, S., Ku, S., Diouf, O., Liu, E., A Barrett, J., Ito, S., et al. (2013).
Infusion of donor-derived CD19-redirected-virus-specific T cells for B-cell malignancies relapsed after allogeneic stem cell transplant: a phase I study.Blood.
2014
Zhou, X., Di Stasi, A., Tey, S.-K., Krance, R.A., Martinez, C., Leung, K.S., Durett, A.G., Wu, M.-F., Liu, H., Leen, A.M., et al. (2014).
Long-term outcome and immune reconstitution after haploidentical stem cell transplant in recipients of allodepleted-T-cells expressing the inducible caspase-9 safety transgene.Blood.
2015
Zhou, X., Dotti, G., Krance, R.A., Martinez, C.A., Naik, S., Kamble, R.T., Durett, A.G., Dakhova, O., Savoldo, B., Di Stasi, A., et al. (2015).
Inducible caspase-9 suicide gene controls adverse effects from alloreplete T cells after haploidentical stem cell transplantation.Blood.
]